Related Experiment Video
Updated: Aug 27, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria
Karen D Weynberg1,2, Paul R Jaschke3
1School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Australia.
Abstract:
Resistance to antibiotics is an escalating global crisis, presenting a major health, social, and economic burden. An underexplored alternative to antibiotic treatment is phage therapy whereby bacteriophages are used to infect and kill pathogenic multidrug-resistant (MDR) bacteria. A primary challenge is the highly specific infectivity range of phages that can limit their ability to infect across different bacterial strains. Synthetic biology can enable the design, modification, and synthesis of phages with improved antimicrobial performance and efficacy to help realize novel strategies to study and treat bacterial infectious diseases, including those caused by MDR pathogens. In this perspective article, we discuss the potential for an innovative synthetic biology approach to enhance phage therapeutics and the role a biofoundry can play in bringing phage therapy to fruition.
Insights
Antibiotic resistance is a global crisis. Synthetic biology can enhance bacteriophage (phage) therapy to combat multidrug-resistant bacteria, with biofoundries playing a key role in its development.
Area of Science:
- Microbiology
- Synthetic Biology
- Biotechnology
Background:
- Antibiotic resistance poses a significant global health threat.
- Phage therapy, using bacteriophages to kill bacteria, is an alternative treatment.
- Phage specificity limits their effectiveness against diverse bacterial strains.
Purpose of the Study:
- To explore synthetic biology's potential for enhancing phage therapeutics.
- To discuss the role of biofoundries in advancing phage therapy.
Main Methods:
- The article is a perspective piece, discussing existing and potential applications.
- It reviews the principles of synthetic biology in phage engineering.
- It highlights the capabilities of biofoundries for scalable phage production and modification.
Main Results:
- Synthetic biology offers tools to engineer phages with broader host ranges and improved efficacy.
- Biofoundries can accelerate the development and deployment of customized phage therapies.
- This approach can overcome limitations of natural phage infectivity.
Conclusions:
- Synthetic biology presents a promising avenue to enhance phage therapy against multidrug-resistant pathogens.
- Biofoundries are crucial for the industrialization and clinical translation of engineered phage therapeutics.
- This innovative strategy could provide a vital solution to the antibiotic resistance crisis.
Related Concept Videos
Lytic Cycle of Bacteriophages
Biological Methods for Microbial Control
DNA Bacteriophages
Antibiotic Selection
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Development of Antibiotic Resistance

